Go Pro
NASDAQ:MDLN

Medline (MDLN) Stock Price, News & Analysis

Medline logo
$34.70 +0.13 (+0.36%)
As of 09:55 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Medline Stock (NASDAQ:MDLN)

Advanced

Key Stats

Today's Range
$34.30
$34.85
50-Day Range
$32.58
$43.19
52-Week Range
$32.49
$50.88
Volume
74,913 shs
Average Volume
7.27 million shs
Market Capitalization
$45.63 billion
P/E Ratio
43.94
Dividend Yield
N/A
Price Target
$47.42
Consensus Rating
Moderate Buy

Company Overview

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations. Its offerings typically include direct delivery, customized kit and procedure-packaging services, inventory management programs and value‑added services such as clinical education and operational consulting. These capabilities are aimed at improving clinical workflow and supporting large, complex supply networks.

Medline operates through an extensive distribution network and serves customers across multiple geographies, with a primary focus on North American healthcare markets alongside international sales and distribution activity. The company is run by an executive leadership team responsible for its commercial, operational and clinical service lines. As a company listed on the NASDAQ under the symbol MDLN, Medline positions itself as an integrated supplier and supply‑chain partner for the healthcare industry.

AI Generated. May Contain Errors.

Medline Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

MDLN MarketRank™: 

Medline scored higher than 75% of companies evaluated by MarketBeat, and ranked 186th out of 918 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medline has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 2 strong buy ratings, 21 buy ratings, 5 hold ratings, and 1 sell rating.

  • Upside Potential

    Medline has a consensus price target of $47.42, representing about 36.6% upside from its current price of $34.71.

  • Amount of Analyst Coverage

    Medline has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medline's stock forecast and price target.
  • Earnings Growth

    Earnings for Medline are expected to decrease by -0.66% in the coming year, from $1.51 to $1.50 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medline is 43.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medline is 43.94, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.19.

  • Price to Earnings Growth Ratio

    Medline has a PEG Ratio of 3.06. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medline has a P/B Ratio of 2.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.77% of the float of Medline has been sold short.
  • Short Interest Ratio / Days to Cover

    Medline has a short interest ratio ("days to cover") of 3.83, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medline has recently increased by 4.65%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Medline does not currently pay a dividend.

  • Dividend Growth

    Medline does not have a long track record of dividend growth.

  • News Sentiment

    Medline has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Medline this week, compared to 8 articles on an average week.
  • Search Interest

    19 people have searched for MDLN on MarketBeat in the last 30 days. This is an increase of 111% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added Medline to their MarketBeat watchlist in the last 30 days. This is an increase of 367% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medline insiders have sold 94,738.33% more of their company's stock than they have bought. Specifically, they have bought $170,750.00 in company stock and sold $161,936,454.00 in company stock.

  • Percentage Held by Insiders

    0.81% of the stock of Medline is held by insiders.

  • Percentage Held by Institutions

    Medline has minimal institutional ownership at this time.

  • Read more about Medline's insider trading history.
Receive MDLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medline and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDLN Stock News Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
Why Medline (MDLN) Stock Is Up Today
See More Headlines

MDLN Stock Analysis - Frequently Asked Questions

Medline's stock was trading at $42.00 at the start of the year. Since then, MDLN stock has decreased by 17.4% and is now trading at $34.7050.

Medline (NASDAQ:MDLN) announced its quarterly earnings results on Wednesday, August, 5th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.32 by $0.18. The firm earned $7.69 billion during the quarter.
Read the conference call transcript
.

Medline (MDLN) raised $7 billion in an initial public offering (IPO) on Wednesday, December 17th 2025. The company issued 248,439,654 shares at a price of $26.00-$30.00 per share.

Medline's top institutional shareholders include H&F Corporate Investors X Ltd. (5.39%), California State Teachers Retirement System (1.74%), Bank of New York Mellon Corp (0.08%) and Readystate Asset Management LP (0.02%). Insiders that own company stock include Group Vii S1 LLC Tc, Aggregator Lp Mozart II, Cp Circle Ml Holdco Gp, Llc, Carlyle Group Inc, Mozart Coinvestment Ho Carlyle, Tc Group Cayman Investment Hol, Private Ltd Gic, Andrew J Mills, Charles N Mills, Hellman & Friedman Capital Par, Douglas P Golwas and Jessi L Corcoran.
View institutional ownership trends
.

Shares of MDLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2026
Today
8/27/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:MDLN
CIK
2046386
Fax
N/A
Employees
45,000
Year Founded
1966

Price Target and Rating

High Price Target
$57.00
Low Price Target
$34.00
Potential Upside/Downside
+38.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
29 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
43.62
Forward P/E Ratio
22.75
P/E Growth
3.06
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
4.33
Quick Ratio
2.61

Sales & Book Value

Annual Sales
$28.43 billion
Price / Sales
1.59
Cash Flow
$1.64 per share
Price / Cash Flow
21.01
Book Value
$14.51 per share
Price / Book
2.37

Miscellaneous

Outstanding Shares
1,314,710,000
Free Float
1,304,058,000
Market Cap
$45.17 billion
Optionable
N/A
Beta
N/A

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:MDLN) was last updated on 8/27/2026 by MarketBeat.com Staff.
From Our Partners